| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
CLINICAL CASE SEMINAR |
Internal Medicine and Endocrinology Unit (S.L., L.M., S.F., A.K., R.C.), Laboratory of Anatomical Pathology (E.L.), and Oto-Rhino-Laryngology Unit (M.R.), University Paris XIII and Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, 93009 Bobigny, France
Address all correspondence and requests for reprints to: Dr. Régis Cohen, Service de Médecine Interne et dEndocrinologie, Hôpital Avicenne, 125 route de Stalingrad, 93009 Bobigny Cedex, France. E-mail: regis.cohen{at}avc.ap-hop-paris.fr.
Plasma cell granuloma (PCG) is a rare, benign inflammatory tumor composed of myofibroblasts, abundant plasma cells, and lymphocytes combined with collagen. A thyroid localization of PCG is extremely rare, and surgical therapy is indicated. We report the case of a 35-yr-old woman with a thyroid PCG, associated with Hashimotos thyroiditis, that was responsible for tracheal compression. Surgery was performed, but the thyroid could not be removed because of the fibrotic process. The patient was treated with corticosteroids and immunosuppressive therapy. Dyspnea and dysphagia improved within 1 month, whereas thyroid volume returned to normal within 3 yr. We also review other reports of thyroid PCG in the literature and discuss the differential diagnosis and treatment. Although the use of immunosuppressive therapy has never been reported for thyroid PCG until now, this treatment may represent a good alternative to surgery in life-threatening, unresectable PCG.
Abbreviations: Ab, Antibody; MRI, magnetic resonance imaging; PCG, plasma cell granuloma; TPO, thyroid peroxidase.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |